Skip to main navigation Skip to search Skip to main content

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification

  • C Heneghan
  • , C Blacklock
  • , R Perera
  • , R Davis
  • , A Banerjee
  • , P Gill
  • , S Liew
  • , L Chamas
  • , J Hernandez
  • , K Mahtani
  • , G Hayward
  • , S Harrison
  • , D Lasserson
  • , S Mickan
  • , C Sellers
  • , D Carnes
  • , K Homer
  • , L Steed
  • , J Ross
  • , N Denny
  • C Goyder, M Thompson, A Ward

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Abstract

Prevalence of non-communicable diseases (NCDs) is increasing globally, with the greatest projected increases in low-income and middle-income countries. We sought to quantify the proportion of Cochrane evidence relating to NCDs derived from such countries.
Original languageEnglish
JournalBMJ Open
Volume3
Issue number7
DOIs
Publication statusPublished - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification'. Together they form a unique fingerprint.

Cite this